DEVA fundamentals

Key facts

Market capitalization‪11.04 B‬TRY
Founded1958
CEOPhilipp Daniel Haas
About

Deva Holding AS engages in the production and marketing of human pharmaceuticals and raw materials. It engages in veterinary medicine, cologne and medical ampoule production. The company was founded on September 22, 1958 and is headquartered in Istanbul, Turkey.

Ownership
‪‪199.99 M‬‬
Closely held shares
‪‪164.40 M‬‬ (82.2%)
Free Float shares
‪‪35.59 M‬‬ (17.8%)
Closely held shares
‪‪164.40 M‬‬ (82.2%)
Free Float shares
‪‪35.59 M‬‬ (17.8%)
Capital structure
Market cap
‪‪11.04 B‬‬
Debt
‪‪6.07 B‬‬
Cash & equivalents
‪‪2.86 B‬‬
Enterprise value
‪‪14.25 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪11.04 B‬‬
Price to earning ratio (P/E)
7.05x
Price to sales ratio (P/S)
0.78x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
7.05x
Price to sales ratio (P/S)
0.78x
Valuation ratios
‪0.00‬
‪0.60‬
‪1.20‬
‪1.80‬
‪2.40‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪2.00‬
‪4.00‬
‪6.00‬
‪8.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−11%‬
‪0%‬
‪11%‬
‪22%‬
‪33%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−2.00 B‬‬
‪0.00‬
‪‪2.00 B‬‬
‪‪4.00 B‬‬
‪‪6.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−1.30 B‬‬
‪0.00‬
‪‪1.30 B‬‬
‪‪2.60 B‬‬
‪‪3.90 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−1.30 B‬‬
‪0.00‬
‪‪1.30 B‬‬
‪‪2.60 B‬‬
‪‪3.90 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Human Medicine
Veterinary and Pesticides
Other
By country
Period: 2023
Turkey

Dividends

Dividend yield, history and sustainability

Dividend summary
2.99%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
0.45%
Last payment
0.25
Last ex-date
Jun 25, 2024
Dividend history
‪0.20%‬
‪0.45%‬
‪0.70%‬
‪0.95%‬
‪1.20%‬
2019
2020
2021
2022
2023
‪0.00‬
‪0.07‬
‪0.14‬
‪0.21‬
‪0.28‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−2.10 B‬‬
‪0.00‬
‪‪2.10 B‬‬
‪‪4.20 B‬‬
‪‪6.30 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪4.50 B‬‬
‪‪9.00 B‬‬
‪‪13.50 B‬‬
‪‪18.00 B‬‬
Assets
Liabilities